CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-16 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +5,000 | $45.28 | $226K | 51,935.72 |
| 2025-01-16 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −5,000 | $68.75 | $344K | 46,935.72 |
| 2025-01-16 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 25,500 | ||
| 2024-12-16 | Lippis Daniel J. CVP, JAPAC | Option exercise 10b5-1 | +2,500 | $45.28 | $113K | 25,689.07 |
| 2024-12-16 | Lippis Daniel J. CVP, JAPAC | Sale 10b5-1 | −2,500 | $74.08 | $185K | 23,189.07 |
| 2024-12-16 | Lippis Daniel J. CVP, JAPAC | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −2,500 | 2,030 | ||
| 2024-12-09 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +11,250 | $45.28 | $509K | 41,811 |
| 2024-12-09 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −11,250 | $71.68 | $806K | 30,561 |
| 2024-12-09 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −11,250 | 45,000 | ||
| 2024-12-09 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +5,000 | $45.28 | $226K | 51,935.72 |
| 2024-12-09 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −5,000 | $71.75 | $359K | 46,935.72 |
| 2024-12-09 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 30,500 | ||
| 2024-12-06 | Chopra Daveen CVP, TMTT | Sale | −1,750 | $73.27 | $128K | 27,583 |
| 2024-12-06 | Markowitz Wayne GM & SVP, Surgical | Sale | −583 | $73.27 | $43K | 9,493.85 |
| 2024-11-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +5,000 | $45.28 | $226K | 51,935.72 |
| 2024-11-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −5,000 | $65.57 | $328K | 46,935.72 |
| 2024-11-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 35,500 | ||
| 2024-11-05 | Wood Larry L Global President TAVR & Surg | Sale 10b5-1 | −25,000 | $65.91 | $1.6M | 198,525.74 |
| 2024-10-15 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +5,000 | $45.28 | $226K | 51,935.72 |
| 2024-10-15 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −5,000 | $69.51 | $348K | 46,935.72 |
Page 19 of 27 · 525 trades